Takasaki, Japan

Fumio Saito

This inventor holds 10 USPTO granted patents. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 1995-1999.


% Patents Active = 100.0

Average Co-Inventor Count = 8.3

ph-index = 1

Forward Citations = 11(Granted Patents)


Location History:

  • Takasaki, JP (1995 - 1999)
  • Gunma, JP (1999)

Company Filing History:


Years Active: 1995-1999

Loading Chart...
10 patents (USPTO):Explore Patents

Title: Fumio Saito: Innovator in Apoptosis Regulation

Introduction: Fumio Saito, a distinguished inventor based in Takasaki, Japan, is known for his groundbreaking contributions in the field of apoptosis regulation. With an impressive portfolio of 10 patents, Saito continues to push the boundaries of innovative research, making significant strides in biotechnology and pharmacology.

Latest Patents: Among his recent patents is a notable invention detailing an apoptosis regulating composition. The primary goal of this invention is to provide a composition that effectively regulates apoptosis, utilizing at least one carbostyril derivative of a specified general formula, along with its salts. This innovation highlights Saito's commitment to developing advanced therapeutic solutions.

Career Highlights: Fumio Saito has built a commendable career at Otsuka Pharmaceutical Company, Limited, a global leader in pharmaceutical development. His work in apoptosis regulation stands out as a key achievement in the company's portfolio, showcasing his dedication to improving healthcare outcomes through innovative research.

Collaborations: Throughout his career, Saito has collaborated with talented coworkers such as Satoru Nakai and Koutoku Aihara. Together, they have worked on various projects, leveraging their combined expertise to enhance the effectiveness of their innovations.

Conclusion: Fumio Saito is a remarkable inventor whose work in apoptosis regulation has advanced the field of biotechnology. His contributions, alongside the collaboration with esteemed colleagues at Otsuka Pharmaceutical Company, Limited, continue to resonate within the scientific community, paving the way for future innovations in pharmacological therapies.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…